FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084574611> ?p ?o ?g. }

• W2084574611 abstract "Abstract The most common cause of death of cancer sufferers is through the occurrence of metastases. The metastatic behaviour of tumour cells is regulated by extracellular growth factors such as hepatocyte growth factor (HGF), a ligand for the c-Met receptor tyrosine kinase, and aberrant expression/activation of the c-Met receptor is closely associated with metastatic progression. Nk4 (also known as Interleukin (IL)32b) is a competitive antagonist of the HGF c-Met system and inhibits c-Met signalling and tumour metastasis. Nk4 has an additional anti-angiogenic activity independent of its HGF-antagonist function. Angiogenesis-inhibitory as well as cancer-specific apoptosis inducing effects make the Nk4 sequence an attractive candidate for gene therapy of cancer. This study investigates the inhibition of tumour metasasis by gene therapy mediated production of Nk4 by the primary tumour. Optimal delivery of anti-cancer genes is vital in order to achieve the highest therapeutic responses. Non-viral plasmid delivery methods have the advantage of safety and ease of production, providing immediate transgene expression, albeit short-lived in most tumours. Sustained presence of anti-angiogenic molecules is preferable with anti-angiogenic therapies, and the long-term expression mediated by Adeno-associated Virus (AAV) might represent a more appropriate delivery in this respect. However, the incubation time required by AAV vectors to reach appropriate gene expression levels hampers efficacy in many fast-growing murine tumour models. Here, we describe murine trials assessing the effects of Nk4 on the spontaneously metastatic Lewis Lung Carcinoma (LLC) model when delivered to primary tumour via plasmid lipofection or AAV2 vector. Intratumoural AAV-Nk4 administration produced the highest therapeutic response with significant reduction in both primary tumour growth and incidence of lung metastases. Plasmid-mediated therapy also significantly reduced metastatic growth, but with moderate reduction in primary subcutaneous tumour growth. Overall, this study demonstrates the potential for Nk4 gene therapy of metastatic tumours, when delivered by AAV or non-viral methods." @default.
• W2084574611 created "2016-06-24" @default.
• W2084574611 creator A5005897810 @default.
• W2084574611 creator A5007484765 @default.
• W2084574611 creator A5014497377 @default.
• W2084574611 creator A5055862780 @default.
• W2084574611 creator A5059812572 @default.
• W2084574611 creator A5065275381 @default.
• W2084574611 creator A5071871771 @default.
• W2084574611 creator A5089428889 @default.
• W2084574611 date "2009-03-09" @default.
• W2084574611 modified "2023-10-06" @default.
• W2084574611 title "Anti-metastatic effects of viral and non-viral mediated Nk4 delivery to tumours" @default.
• W2084574611 cites W1520383830 @default.
• W2084574611 cites W1964218515 @default.
• W2084574611 cites W1989401198 @default.
• W2084574611 cites W1999545292 @default.
• W2084574611 cites W2018672261 @default.
• W2084574611 cites W2032761083 @default.
• W2084574611 cites W2044673446 @default.
• W2084574611 cites W2050983091 @default.
• W2084574611 cites W2067599479 @default.
• W2084574611 cites W2071663634 @default.
• W2084574611 cites W2105199681 @default.
• W2084574611 cites W2140514512 @default.
• W2084574611 cites W2142506300 @default.
• W2084574611 cites W2164880000 @default.
• W2084574611 cites W2170370631 @default.
• W2084574611 cites W2334123383 @default.
• W2084574611 doi "https://doi.org/10.1186/1479-0556-7-5" @default.
• W2084574611 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2669068" @default.
• W2084574611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19272140" @default.
• W2084574611 hasPublicationYear "2009" @default.
• W2084574611 type Work @default.
• W2084574611 sameAs 2084574611 @default.
• W2084574611 citedByCount "13" @default.
• W2084574611 countsByYear W20845746112013 @default.
• W2084574611 countsByYear W20845746112014 @default.
• W2084574611 countsByYear W20845746112015 @default.
• W2084574611 countsByYear W20845746112016 @default.
• W2084574611 crossrefType "journal-article" @default.
• W2084574611 hasAuthorship W2084574611A5005897810 @default.
• W2084574611 hasAuthorship W2084574611A5007484765 @default.
• W2084574611 hasAuthorship W2084574611A5014497377 @default.
• W2084574611 hasAuthorship W2084574611A5055862780 @default.
• W2084574611 hasAuthorship W2084574611A5059812572 @default.
• W2084574611 hasAuthorship W2084574611A5065275381 @default.
• W2084574611 hasAuthorship W2084574611A5071871771 @default.
• W2084574611 hasAuthorship W2084574611A5089428889 @default.
• W2084574611 hasBestOaLocation W20845746111 @default.
• W2084574611 hasConcept C101544691 @default.
• W2084574611 hasConcept C104317684 @default.
• W2084574611 hasConcept C111599444 @default.
• W2084574611 hasConcept C121608353 @default.
• W2084574611 hasConcept C126322002 @default.
• W2084574611 hasConcept C135983454 @default.
• W2084574611 hasConcept C170493617 @default.
• W2084574611 hasConcept C203014093 @default.
• W2084574611 hasConcept C2776996007 @default.
• W2084574611 hasConcept C2779013556 @default.
• W2084574611 hasConcept C2780394083 @default.
• W2084574611 hasConcept C42362537 @default.
• W2084574611 hasConcept C502942594 @default.
• W2084574611 hasConcept C55493867 @default.
• W2084574611 hasConcept C71924100 @default.
• W2084574611 hasConcept C86803240 @default.
• W2084574611 hasConceptScore W2084574611C101544691 @default.
• W2084574611 hasConceptScore W2084574611C104317684 @default.
• W2084574611 hasConceptScore W2084574611C111599444 @default.
• W2084574611 hasConceptScore W2084574611C121608353 @default.
• W2084574611 hasConceptScore W2084574611C126322002 @default.
• W2084574611 hasConceptScore W2084574611C135983454 @default.
• W2084574611 hasConceptScore W2084574611C170493617 @default.
• W2084574611 hasConceptScore W2084574611C203014093 @default.
• W2084574611 hasConceptScore W2084574611C2776996007 @default.
• W2084574611 hasConceptScore W2084574611C2779013556 @default.
• W2084574611 hasConceptScore W2084574611C2780394083 @default.
• W2084574611 hasConceptScore W2084574611C42362537 @default.
• W2084574611 hasConceptScore W2084574611C502942594 @default.
• W2084574611 hasConceptScore W2084574611C55493867 @default.
• W2084574611 hasConceptScore W2084574611C71924100 @default.
• W2084574611 hasConceptScore W2084574611C86803240 @default.
• W2084574611 hasIssue "1" @default.
• W2084574611 hasLocation W20845746111 @default.
• W2084574611 hasLocation W20845746112 @default.
• W2084574611 hasLocation W20845746113 @default.
• W2084574611 hasLocation W20845746114 @default.
• W2084574611 hasOpenAccess W2084574611 @default.
• W2084574611 hasPrimaryLocation W20845746111 @default.
• W2084574611 hasRelatedWork W1511529197 @default.
• W2084574611 hasRelatedWork W1564365085 @default.
• W2084574611 hasRelatedWork W1966290213 @default.
• W2084574611 hasRelatedWork W1983822371 @default.
• W2084574611 hasRelatedWork W2102140960 @default.
• W2084574611 hasRelatedWork W2117151547 @default.
• W2084574611 hasRelatedWork W2212445284 @default.
• W2084574611 hasRelatedWork W2314935751 @default.
• W2084574611 hasRelatedWork W4254511875 @default.
• W2084574611 hasRelatedWork W4283771460 @default.
• W2084574611 hasVolume "7" @default.

• next